Navigation Links
Abbott Laboratories to buy Biocompatibles' cardiovascular stent business

Abbott Laboratories said it has agreed to acquire the cardiovascular stent business of Biocompatibles International PLC for $234.5 million in cash. Abbott said the deal will strengthen its portfolio of products and will expand its international presence in the vascular business for polymer-coated stents - tiny metal tubes that keep blood vessels open.//

Abbott has been the exclusive U.S. distributor of the British company's BiodivYsio coated stents since 1999. The pharmaceutical and medical device manufacturer also will assume worldwide commercial rights for all potential drug-coated stent products in Biocompatibles' pipeline.

Abbott Laboratories said it expects the deal to be completed in the second quarter. Abbott shares fell 71 cents to $53.30 in trading on the New York Stock Exchange.
'"/>




Page: 1

Related medicine news :

1. Pharmacia may take 51.5 percent Abbott stake
2. Abbott’s Laboratories R&D Capabilities Questione
3. Abbott Receives CE Mark Certification
4. Abbott to Subsidize Price of HIV Drug
5. Abbott Offers Aluvia to Thailand in Return for Compulsory Licensing Halt
6. Dr Reddy’s Laboratories to challenge patents on drug
7. Dr Reddy’s Laboratories launches Hyalosy
8. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
9. Abbott’s Laboratories R&D Capabilities Questione
10. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
11. ICMR to Set up Laboratories to Combat Bird Flu
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... September 25, 2017 , ... SignatureCare Emergency Center ... The $1000 student scholarship is awarded each semester to a deserving student. Congratulations ... who is a medical student at Arizona State University with a 3.63 GPA. ...
(Date:9/25/2017)... ... September 25, 2017 , ... Microsoft Ignite Conference ... up to deliver Netmail’s Hadron Data Auditing and eDiscovery services to healthcare organizations ... demoing their Hadron solution in a HIPAA/HITRUST Azure Cloud at the Microsoft Ignite ...
(Date:9/25/2017)... ... September 25, 2017 , ... Just ask anyone old enough ... or 1980s, with headgear so wired up and containing so much metal that jokes ... so discreet that its treatments can barely be observed. As a result, it’s now ...
(Date:9/25/2017)... ... September 25, 2017 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that two of its leading ... bioassays at two upcoming conferences. , At the BEBPA 10th Annual Bioassay Conference, ...
(Date:9/25/2017)... ... September 25, 2017 , ... International Water Advocate Sharon ... Kleyne Hour Power of Water, Global Climate Change and Your Health on VoiceAmerica ... from a once-every-four-years series of events to a personal, daily Health Olympics. “Wouldn’t ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... STOCKHOLM , Sept. 7, 2017 NuvoAir ... Air Smart Spirometer, announced today a partnership with Novartis Pharma ... partnership solidifies NuvoAir,s position as the leading mobile spirometry platform ... respiratory patients. ... spirometry test ...
(Date:9/6/2017)... 6, 2017  Medical professionals are expected ... while treating their patients. Medical simulations offer ... involving patients. Simulation provides a safe method ... out procedures, refine techniques and build confidence, ... new technology, such as augmented reality, will ...
Breaking Medicine Technology: